Skip to content

Value of Electrothermal Denervation during Arthroscopic Debridement of Anterior Ankle Impingement – A Prospective Randomised Study

Value of Electrothermal Denervation during Arthroscopic Debridement of Anterior Ankle Impingement – A Prospective Randomised Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025703
Enrollment
58
Registered
2021-06-24
Start date
2019-06-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impingement syndrome of the ankle joint Nonspecific ankle pain

Interventions

Group 1: Group A: Arthoroscopic Debridement WITH Electrothermal Denervation Group 2: Group B: Arthoroscopic Debridement WITHOUT Electrothermal Denervation

Sponsors

BG Unfallklinik Frankfurt am Main
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Isolated impingement of the ankle joint - Minimum age 18 years - General operability given - Ability to give informed consent given (§ 40 Para. 1 Sentence 1 No. 3 AMG) - Written informed consent for participation in the study is available - Isolated arthroscopy of the upper ankle joint with debridement and electrothermal denervation without additional intervention

Exclusion criteria

Exclusion criteria: - Inclusion criteria not met - Generalized arthrofibrosis - Known coagulation disorder - Known increased risk of thromboembolism - Chronic pain that is not due to the ankle joint to be operated on BMI > 35 (obesity grade I) - Patients with chronic painkiller abuse - Higher grade (> 2°) insufficiency of the fibular ligament structures and deltoid ligament - High-grade (> 2° large-surface, >3° small-surface) arthritic changes of the tibial and talar articular surface - Necessity of peri-/postoperative analgesia by means of pain catheters - Extension of intervention (e.g. cartilage repair), switch to open procedure

Design outcomes

Primary

MeasureTime frame
Primary target: 48-h postoperative VAS score (visual analog scale pain).

Secondary

MeasureTime frame
Evaluation of secondary outcome measures such as redon's suction drainage delivery rate 24h postoperatively, range of motion, AOFAS-AH scores, the FFI, and the VAS FA each before and 6 weeks after surgery.

Countries

Germany

Contacts

Public ContactSebastian Fischer

BG Unfallklinik Frankfurt am Main

dr.sebastian.fischer@me.com+49(0)69/475-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026